title: Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy.
authors.forename: J
authors.initials: J
authors.lastname: Mateos
authors.forename: J A
authors.initials: JA
authors.lastname: Pérez-Simón
authors.forename: D
authors.initials: D
authors.lastname: Caballero
authors.forename: C
authors.initials: C
authors.lastname: Castilla
authors.forename: O
authors.initials: O
authors.lastname: Lopez
authors.forename: E
authors.initials: E
authors.lastname: Perez
authors.forename: C
authors.initials: C
authors.lastname: Cañizo
authors.forename: L
authors.initials: L
authors.lastname: Vazquez
authors.forename: J F
authors.initials: JF
authors.lastname: San Miguel
mesh_terms: D000293:Adolescent; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D002648:Child; D005260:Female; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology; D014182:Transplantation, Autologous; D014750:Vincristine / Q000008:administration & dosage*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine